Natixis’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.6M | Buy |
338,711
+269,479
| +389% | +$58M | 0.26% | 54 |
|
|
2025
Q4 | $14.2M | Sell |
69,232
-175,439
| -72% | -$33M | 0.05% | 270 |
|
|
2025
Q3 | $38.4M | Buy |
244,671
+158,620
| +184% | +$24.5M | 0.18% | 104 |
|
|
2025
Q2 | $14.5M | Sell |
86,051
-72,854
| -46% | -$10.8M | 0.06% | 187 |
|
|
2025
Q1 | $21.8M | Buy |
158,905
+50,378
| +46% | +$6.42M | 0.12% | 137 |
|
|
2024
Q4 | $12.8M | Buy |
108,527
+81,023
| +295% | +$9.46M | 0.08% | 186 |
|
|
2024
Q3 | $3.04M | Buy |
27,504
+304
| +1% | +$31.8K | 0.02% | 378 |
|
|
2024
Q2 | $2.67M | Sell |
27,200
-10,930
| -29% | -$1.11M | 0.02% | 370 |
|
|
2024
Q1 | $4.27M | Buy |
38,130
+22,700
| +147% | +$2.45M | 0.02% | 332 |
|
|
2023
Q4 | $1.56M | Sell |
15,430
-300
| -2% | -$29.8K | 0.01% | 455 |
|
|
2023
Q3 | $1.37M | Sell |
15,730
-16,621
| -51% | -$1.5M | 0.01% | 458 |
|
|
2023
Q2 | $3.06M | Buy |
32,351
+6,342
| +24% | +$536K | 0.02% | 358 |
|
|
2023
Q1 | $1.96M | Sell |
26,009
-70,516
| -73% | -$5.32M | 0.02% | 416 |
|
|
2022
Q4 | $7.42M | Sell |
96,525
-59,325
| -38% | -$4.51M | 0.04% | 313 |
|
|
2022
Q3 | $10.4M | Buy |
155,850
+79,023
| +103% | +$5.01M | 0.05% | 274 |
|
|
2022
Q2 | $4.03M | Sell |
76,827
-246,716
| -76% | -$14M | 0.01% | 493 |
|
|
2022
Q1 | $18.3M | Buy |
323,543
+187,626
| +138% | +$10M | 0.06% | 279 |
|
|
2021
Q4 | $7M | Buy |
135,917
+110,336
| +431% | +$5.41M | 0.02% | 483 |
|
|
2021
Q3 | $1.26M | Sell |
25,581
-54,034
| -68% | -$2.93M | ﹤0.01% | 824 |
|
|
2021
Q2 | $4.54M | Buy |
79,615
+43,473
| +120% | +$2.54M | 0.02% | 402 |
|
|
2021
Q1 | $2.2M | Sell |
36,142
-219,485
| -86% | -$12.1M | 0.01% | 678 |
|
|
2020
Q4 | $13.7M | Buy |
255,627
+196,727
| +334% | +$10.2M | 0.05% | 333 |
|
|
2020
Q3 | $2.77M | Buy |
+58,900
| New | +$3.02M | 0.02% | 365 |
|
|
2020
Q2 | – | Sell |
-122,497
| Closed | -$5.87M | – | 741 |
|
|
2020
Q1 | $5.87M | Buy |
+122,497
| New | +$6.36M | 0.05% | 255 |
|
|
2019
Q4 | – | Sell |
-42,097
| Closed | -$1.99M | – | 846 |
|
|
2019
Q3 | $1.99M | Buy |
+42,097
| New | +$1.92M | 0.01% | 491 |
|
|
2019
Q1 | – | Sell |
-105,295
| Closed | -$4.7M | – | 789 |
|
|
2018
Q4 | $4.7M | Sell |
105,295
-210,534
| -67% | -$11M | 0.04% | 331 |
|
|
2018
Q3 | $17.1M | Buy |
315,829
+307,280
| +3,594% | +$15.7M | 0.1% | 197 |
|
|
2018
Q2 | $417K | Sell |
8,549
-71,927
| -89% | -$4.08M | ﹤0.01% | 721 |
|
|
2018
Q1 | $5.04M | Buy |
80,476
+74,158
| +1,174% | +$5.09M | 0.03% | 362 |
|
|
2017
Q4 | $387K | Buy |
+6,318
| New | +$391K | ﹤0.01% | 635 |
|
|
2017
Q3 | – | Sell |
-7,318
| Closed | -$570K | – | 1254 |
|
|
2017
Q2 | $570K | Buy |
+7,318
| New | +$552K | 0.01% | 491 |
|
|
2015
Q4 | – | Sell |
-6,962
| Closed | -$535K | – | 318 |
|
|
2015
Q3 | $535K | Buy |
+6,962
| New | +$582K | 0.01% | 192 |
|
|
2015
Q2 | – | Sell |
-4,192
| Closed | -$378K | – | 376 |
|
|
2015
Q1 | $378K | Sell |
4,192
-4,338
| -51% | -$373K | 0.01% | 329 |
|
|
2014
Q4 | $689K | Buy |
8,530
+3,643
| +75% | +$288K | 0.01% | 262 |
|
|
2014
Q3 | $366K | Buy |
4,887
+494
| +11% | +$35.9K | 0.01% | 333 |
|
|
2014
Q2 | $301K | Sell |
4,393
-981
| -18% | -$66.8K | ﹤0.01% | 400 |
|
|
2014
Q1 | $376K | Sell |
5,374
-2,300
| -30% | -$160K | ﹤0.01% | 388 |
|
|
2013
Q4 | $514K | Buy |
+7,674
| New | +$469K | ﹤0.01% | 400 |
|
Other funds holding CAH
VCM
VPM
Natixis's CAH Position: Q1 2026 in Review
Natixis increased its Cardinal Health (CAH) stake by 389% in Q1 2026, buying an estimated $58M and bringing the position to 338,711 shares worth $71.6M. The position accounts for 0.26% of the portfolio, ranked #54.
Natixis first reported a position in CAH in Q4 2013 and has held it in 38 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Natixis held 338,711 shares of Cardinal Health worth $71.6M as of Q1 2026.
- Natixis bought 269,479 Cardinal Health shares in Q1 2026, an estimated $58M.
- Cardinal Health made up 0.26% of Natixis's portfolio in Q1 2026, its #54 holding.
- Natixis first reported a position in Cardinal Health in Q4 2013 and has held it in 38 quarters since.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.